Abstract
Observational studies have suggested a possible protective role of vitamin D on the cardiovascular system. The available evidence does not support either cardiovascular benefits or harms of vitamin D supplementation. This chapter provides an overview and discussion of the current knowledge of vitamin D effects from a cardiovascular health perspective. It focuses on vitamin D in relation to cardiovascular disease, i.e. ischemic heart disease, and stroke; the traditional cardiovascular risk factors hypertension, abnormal blood lipids, obesity; and the emerging risk factors hyperparathyroidism, microalbuminuria, chronic obstructive pulmonary diseases, and non-alcoholic fatty liver disease. Meta-analyses of observational studies have largely found vitamin D levels to be inversely associated with cardiovascular risk and disease. However, Mendelian randomization studies and randomized, controlled trials (RCTs) have not been able to consistently replicate the observational findings. Several RCTs are ongoing, and the results from these are needed to clarify whether vitamin D deficiency is a causal and reversible factor to prevent cardiovascular disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Holick MF (2007) Vitamin D deficiency. N Engl J Med 357(3):266–281
Hilger J, Friedel A, Herr R, Rausch T, Roos F, Wahl DA et al (2013) A systematic review of vitamin D status in populations worldwide. Br J Nutr 9:1–23
Thuesen B, Husemoen L, Fenger M, Jakobsen J, Schwarz P, Toft U et al (2012) Determinants of vitamin D status in a general population of Danish adults. Bone 50(3):605–610
Skaaby T, Husemoen LL, Thuesen BH, Pisinger C, Hannemann A, Jorgensen T et al (2015) Longitudinal associations between lifestyle and vitamin D: a general population study with repeated vitamin D measurements. Endocrine 51(2):342–350
Levy MA, McKinnon T, Barker T, Dern A, Helland T, Robertson J et al (2015) Predictors of vitamin D status in subjects that consume a vitamin D supplement. Eur J Clin Nutr 69(1):84–89
Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG et al (2014) Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 1:CD007470
Jorde R, Schirmer H, Wilsgaard T, Joakimsen RM, Mathiesen EB, Njolstad I et al (2012) Polymorphisms related to the serum 25-hydroxyvitamin D level and risk of myocardial infarction, diabetes, cancer and mortality. The tromso study. PLoS One 7(5):e37295
Skaaby T, Husemoen LL, Pisinger C, Jorgensen T, Thuesen BH, Fenger M et al (2012) Vitamin D status and cause-specific mortality: a general population study. PLoS One 7(12):e52423
Skaaby T, Husemoen LL, Pisinger C, Jorgensen T, Thuesen BH, Fenger M et al (2013) Vitamin D status and incident cardiovascular disease and all-cause mortality: a general population study. Endocrine 43(3):618–625
Theodoratou E, Tzoulaki I, Zgaga L, Ioannidis JP (2014) Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ 348:g2035
Trummer O, Pilz S, Hoffmann MM, Winkelmann BR, Boehm BO, Marz W et al (2013) Vitamin D and mortality: a Mendelian randomization study. Clin Chem 59(5):793–797
Skaaby T, Husemoen LL, Thuesen BH, Pisinger C, Jorgensen T, Roswall N et al (2014) Prospective population-based study of the association between serum 25-hydroxyvitamin-D levels and the incidence of specific types of cancer. Cancer Epidemiol Biomark Prev 23(7):1220–1229
Muldowney S, Kiely M (2010) Vitamin D and cardiometabolic health: a review of the evidence. Nutr Res Rev 1:1–20
Steingrimsdottir L, Gunnarsson O, Indridason OS, Franzson L, Sigurdsson G (2005) Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA 294(18):2336–2341
Cho HJ, Kang HC, Choi SA, Ju YC, Lee HS, Park HJ (2005) The possible role of Ca2+ on the activation of microsomal triglyceride transfer protein in rat hepatocytes. Biol Pharm Bull 28(8):1418–1423
de Boer IH, Ioannou GN, Kestenbaum B, Brunzell JD, Weiss NS (2007) 25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis 50(1):69–77
Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J (2004) Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol 89-90(1-5):387–392
Tomaschitz A, Pilz S, Ritz E, Grammer T, Drechsler C, Boehm BO et al (2010) Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: the ludwigshafen risk and cardiovascular health (LURIC) study. Clin Chim Acta 411(17-18):1354–1360
Zagura M, Serg M, Kampus P, Zilmer M, Eha J, Unt E et al (2011) Aortic stiffness and vitamin D are independent markers of aortic calcification in patients with peripheral arterial disease and in healthy subjects. Eur J Vasc Endovasc Surg 42(5):689–695
Shi H, Norman AW, Okamura WH, Sen A, Zemel MB (2001) 1alpha,25-Dihydroxyvitamin D3 modulates human adipocyte metabolism via nongenomic action. FASEB J 15(14):2751–2753
Fassina G, Maragno I, Dorigo P, Contessa AR (1969) Effect of vitamin D2 on hormone-stimulated lipolysis in vitro. Eur J Pharmacol 5(3):286–290
Chiu KC, Chu A, Go VL, Saad MF (2004) Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 79(5):820–825
Dobak J, Grzybowski J, Liu FT, Landon B, Dobke M (1994) 1,25-Dihydroxyvitamin D3 increases collagen production in dermal fibroblasts. J Dermatol Sci 8(1):18–24
Barchetta I, Angelico F, Del BM, Baroni MG, Pozzilli P, Morini S et al (2011) Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC Med 9:85
Targher G, Bertolini L, Scala L, Cigolini M, Zenari L, Falezza G et al (2007) Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 17(7):517–524
Messenger W, Nielson CM, Li H, Beer T, Barrett-Connor E, Stone K et al (2011) Serum and dietary vitamin D and cardiovascular disease risk in elderly men: a prospective cohort study. Nutr Metab Cardiovasc Dis 22(10):856–863
Melamed ML, Michos ED, Post W, Astor B (2008) 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 168(15):1629–1637
Kilkkinen A, Knekt P, Aro A, Rissanen H, Marniemi J, Heliovaara M et al (2009) Vitamin D status and the risk of cardiovascular disease death. Am J Epidemiol 170(8):1032–1039
Ginde AA, Scragg R, Schwartz RS, Camargo CA Jr (2009) Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J Am Geriatr Soc 57(9):1595–1603
Pilz S, Dobnig H, Nijpels G, Heine RJ, Stehouwer CD, Snijder MB et al (2009) Vitamin D and mortality in older men and women. Clin Endocrinol 71(5):666–672
Semba RD, Houston DK, Bandinelli S, Sun K, Cherubini A, Cappola AR et al (2010) Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults. Eur J Clin Nutr 64(2):203–209
Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K et al (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation 117(4):503–511
Hosseinpanah F, Yarjanli M, Sheikholeslami F, Heibatollahi M, Eskandary PS, Azizi F (2011) Associations between vitamin D and cardiovascular outcomes; Tehran Lipid and glucose study. Atherosclerosis 218(1):238–242
Brondum-Jacobsen P, Benn M, Jensen GB, Nordestgaard BG (2012) 25-hydroxyvitamin d levels and risk of ischemic heart disease, myocardial infarction, and early death: population-based study and meta-analyses of 18 and 17 studies. Arterioscler Thromb Vasc Biol 32(11):2794–2802
Chowdhury R, Kunutsor S, Vitezova A, Oliver-Williams C, Chowdhury S, Kiefte-de-Jong JC et al (2014) Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 348:g1903
Fan H, Yu W, Cao H, Li J, Liu B, Wang J et al (2014) Meta-analysis of circulating 25-hydroxyvitamin D levels and risk of cardiovascular and all-cause mortality in elderly population. Int J Cardiol 176(3):1025–1029
Grandi NC, Breitling LP, Brenner H (2010) Vitamin D and cardiovascular disease: systematic review and meta-analysis of prospective studies. Prev Med 51(3-4):228–233
Pittas AG, Chung M, Trikalinos T, Mitri J, Brendel M, Patel K et al (2010) Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med 152(5):307–314
Schottker B, Jorde R, Peasey A, Thorand B, Jansen EH, Groot L et al (2014) Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States. BMJ 348:g3656
Sokol SI, Tsang P, Aggarwal V, Melamed ML, Srinivas VS (2011) Vitamin D status and risk of cardiovascular events: lessons learned via systematic review and meta-analysis. Cardiol Rev 19(4):192–201
Tomson J, Emberson J, Hill M, Gordon A, Armitage J, Shipley M et al (2013) Vitamin D and risk of death from vascular and non-vascular causes in the Whitehall study and meta-analyses of 12,000 deaths. Eur Heart J 34(18):1365–1374
Wang L, Song Y, Manson JE, Pilz S, Marz W, Michaelsson K et al (2012) Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes 5(6):819–829
Avenell A, MacLennan GS, Jenkinson DJ, McPherson GC, McDonald AM, Pant PR et al (2012) Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D(3) and/or calcium (RECORD trial). J Clin Endocrinol Metab 97(2):614–622
Ford JA, MacLennan GS, Avenell A, Bolland M, Grey A, Witham M (2014) Cardiovascular disease and vitamin D supplementation: trial analysis, systematic review, and meta-analysis. Am J Clin Nutr 100(3):746–755
Bolland MJ, Grey A, Gamble GD, Reid IR (2014) The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diabetes Endocrinol 2(4):307–320
Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG et al (2011) Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 7:CD007470
Song Y, Wang L, Pittas AG, Del Gobbo LC, Zhang C, Manson JE et al (2013) Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care 36(5):1422–1428
Khan H, Kunutsor S, Franco OH, Chowdhury R (2013) Vitamin D, type 2 diabetes and other metabolic outcomes: a systematic review and meta-analysis of prospective studies. Proc Nutr Soc 72(1):89–97
Ju SY, Jeong HS (2014) Kim dH. Blood vitamin D status and metabolic syndrome in the general adult population: a dose-response meta-analysis. J Clin Endocrinol Metab 99(3):1053–1063
Mallika V, Goswami B, Rajappa M (2007) Atherosclerosis pathophysiology and the role of novel risk factors: a clinicobiochemical perspective. Angiology 58(5):513–522
Skaaby T, Husemoen LL, Pisinger C, Jorgensen T, Thuesen BH, Fenger M et al (2012) Vitamin D status and changes in cardiovascular risk factors: a prospective study of a general population. Cardiology 123(1):62–70
Jorde R, Figenschau Y, Hutchinson M, Emaus N, Grimnes G (2010) High serum 25-hydroxyvitamin D concentrations are associated with a favorable serum lipid profile. Eur J Clin Nutr 64(12):1457–1464
Kelishadi R, Farajzadegan Z, Bahreynian M (2014) Association between vitamin D status and lipid profile in children and adolescents: a systematic review and meta-analysis. Int J Food Sci Nutr 65(4):404–410
Jorde R, Grimnes G (2011) Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids. Prog Lipid Res 50(4):303–312
Elamin MB, Abu Elnour NO, Elamin KB, Fatourechi MM, Alkatib AA, Almandoz JP et al (2011) Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J Clin Endocrinol Metab 96(7):1931–1942
Challoumas D (2014) Vitamin D supplementation and lipid profile: what does the best available evidence show? Atherosclerosis 235(1):130–139
Pereira-Santos M, Costa PR, Assis AM, Santos CA, Santos DB (2015) Obesity and vitamin D deficiency: a systematic review and meta-analysis. Obes Rev 16(4):341–349
Vimaleswaran KS, Berry DJ, Lu C, Tikkanen E, Pilz S, Hiraki LT et al (2013) Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med 10(2):e1001383
Parikh SJ, Edelman M, Uwaifo GI, Freedman RJ, Semega-Janneh M, Reynolds J et al (2004) The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab 89(3):1196–1199
Pathak K, Soares MJ, Calton EK, Zhao Y, Hallett J (2014) Vitamin D supplementation and body weight status: a systematic review and meta-analysis of randomized controlled trials. Obes Rev 15(6):528–537
Chandler PD, Wang L, Zhang X, Sesso HD, Moorthy MV, Obi O et al (2015) Effect of vitamin D supplementation alone or with calcium on adiposity measures: a systematic review and meta-analysis of randomized controlled trials. Nutr Rev 73(9):577–593
Alexander RW (1995) Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension 25(2):155–161
Witham MD, Nadir MA, Struthers AD (2009) Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J Hypertens 27(10):1948–1954
Burgaz A, Orsini N, Larsson SC, Wolk A (2011) Blood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis. J Hypertens 29(4):636–645
Kunutsor SK, Apekey TA, Steur M (2013) Vitamin D and risk of future hypertension: meta-analysis of 283,537 participants. Eur J Epidemiol 28(3):205–221
Vimaleswaran KS, Cavadino A, Berry DJ, Jorde R, Dieffenbach AK, Lu C et al (2014) Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study. Lancet Diabetes Endocrinol 2(9):719–729
Forman JP, Scott JB, Ng K, Drake BF, Suarez EG, Hayden DL et al (2013) Effect of vitamin D supplementation on blood pressure in blacks. Hypertension 61(4):779–785
Larsen T, Mose FH, Bech JN, Hansen AB, Pedersen EB (2012) Effect of cholecalciferol supplementation during winter months in patients with hypertension: a randomized, placebo-controlled trial. Am J Hypertens 25(11):1215–1222
Skaaby T, Husemoen LL, Pisinger C, Jorgensen T, Thuesen BH, Rasmussen K et al (2013) Vitamin D status and 5-year changes in urine albumin creatinine ratio and parathyroid hormone in a general population. Endocrine 44(2):473–480
Hagstrom E, Hellman P, Larsson TE, Ingelsson E, Berglund L, Sundstrom J et al (2009) Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 119(21):2765–2771
de ZD RG, Parving HH, Keane WF, Zhang Z, Shahinfar S et al (2004) Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 110(8):921–927
O’Seaghdha CM, Hwang SJ, Holden R, Booth SL, Fox CS (2012) Phylloquinone and vitamin D status: associations with incident chronic kidney disease in the Framingham Offspring cohort. Am J Nephrol 36(1):68–77
Joergensen C, Tarnow L, Goetze JP, Rossing P (2014) Vitamin D analogue therapy, cardiovascular risk and kidney function in people with Type 1 diabetes mellitus and diabetic nephropathy: a randomized trial. Diabet Med 32(3):374–381
Stone IS, Barnes NC, Petersen SE (2012) Chronic obstructive pulmonary disease: a modifiable risk factor for cardiovascular disease? Heart 98(14):1055–1062
Sin DD, Man SF (2005) Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc 2(1):8–11
Skaaby T, Husemoen LL, Thuesen BH, Pisinger C, Jorgensen T, Fenger RV et al (2014) Vitamin d status and chronic obstructive pulmonary disease: a prospective general population study. PLoS One 9(3):e90654
Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C (2016) Nonalcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis of observational studies. J Hepatol 65(3):589–600
Putz-Bankuti C, Pilz S, Stojakovic T, Scharnagl H, Pieber TR, Trauner M et al (2012) Association of 25-hydroxyvitamin D levels with liver dysfunction and mortality in chronic liver disease. Liver Int 32(5):845–851
Skaaby T, Husemoen LL, Borglykke A, Jorgensen T, Thuesen BH, Pisinger C et al (2013) Vitamin D status, liver enzymes, and incident liver disease and mortality: a general population study. Endocrine 47(1):213–220
Skaaby T, Husemoen LL, Linneberg A (2013) Does liver damage explain the inverse association between vitamin D status and mortality? Ann Epidemiol 23(12):812–814
Bolland MJ, Grey A, Avenell A, Gamble GD, Reid IR (2011) Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women’s Health Initiative limited access dataset and meta-analysis. BMJ 342:d2040
Kupferschmidt K (2012) Uncertain verdict as vitamin D goes on trial. Science 337(6101):1476–1478
Pilz S, Rutters F, Dekker JM (2012) Disease prevention: vitamin D trials. Science 338(6109):883
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Skaaby, T., Thuesen, B.H., Linneberg, A. (2017). Vitamin D, Cardiovascular Disease and Risk Factors. In: Ahmad, S. (eds) Ultraviolet Light in Human Health, Diseases and Environment. Advances in Experimental Medicine and Biology, vol 996. Springer, Cham. https://doi.org/10.1007/978-3-319-56017-5_18
Download citation
DOI: https://doi.org/10.1007/978-3-319-56017-5_18
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-56016-8
Online ISBN: 978-3-319-56017-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)